GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Guardant Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$157.88−0.72 (-0.45%)
Close on Oct 19, 2026
- Market cap
- $20.98B
- P/E (TTM)
- –
- Dividend yield
- –
Guardant Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Guardant Health | Industry median |
|---|---|---|
| Market Cap | $21.19B | $1.14B |
| Enterprise Value | $20.13B | $1.35B |
| PS Ratio | 17.91 | 1.63 |
Enterprise value
| Measure | Guardant Health | Industry median |
|---|---|---|
| EV / Sales | 17.02 | 1.78 |
Income (trailing twelve months)
| Measure | Guardant Health | Industry median |
|---|---|---|
| Revenue | $1.18B | $561.90M |
| Gross Profit | $769.16M | $173.32M |
| Operating Income | -$470.26M | -$1.81M |
| Pretax Income | -$454.47M | -$572.42K |
| Net Income | -$453.44M | -$1.16M |
| EBITDA | -$431.80M | -$20.72K |
| EPS (Diluted) | -$3.49 | -$0.02 |
Margins
| Measure | Guardant Health | Industry median |
|---|---|---|
| Gross Margin | 65.0% | 33.1% |
| Operating Margin | -39.7% | -4.45% |
| Pretax Margin | -38.4% | 1.54% |
| Profit Margin | -38.3% | -2.91% |
| EBITDA Margin | -36.5% | 2.41% |
| FCF Margin | -20.3% | 3.13% |
Returns
| Measure | Guardant Health | Industry median |
|---|---|---|
| Return on Assets (ROA) | -28.0% | -3.06% |
| Return on Capital Employed (ROCE) | -29.9% | -0.57% |
Growth
| Measure | Guardant Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 42.7% | 6.92% |
| Revenue Growth (3Y CAGR) | 29.8% | 10.9% |
| Revenue Growth (5Y CAGR) | 27.9% | 13.2% |
Balance sheet
| Measure | Guardant Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.05B | $48.71M |
| Net Cash (Debt) | $1.05B | $205.49K |
| Net Cash Per Share | $7.85 | $0.01 |
| Equity (Book Value) | -$222.87M | $235.16M |
| Book Value Per Share | -$1.66 | $3.48 |
| Tangible Book Value | -$325.39M | $703.69K |
| Working Capital | $1.03B | $30.48M |
Financial position
| Measure | Guardant Health | Industry median |
|---|---|---|
| Current Ratio | 4.03 | 1.40 |
| Quick Ratio | 3.53 | 1.02 |
| Interest Coverage | -97.65 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Guardant Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$185.19M | $3.10M |
| Capital Expenditures | -$55.54M | -$18.62M |
| Free Cash Flow | -$240.72M | $23.73M |
| FCF Per Share | -$1.79 | $0.37 |
Efficiency
| Measure | Guardant Health | Industry median |
|---|---|---|
| Asset Turnover | 0.73 | 0.87 |
| Inventory Turnover | 4.37 | 11.67 |
| Revenue Per Employee | $472.11K | $228.48K |
| Profits Per Employee | -$180.94K | -$8.65K |
| Employee Count | 2,506 | 913 |
Dividends and yields
| Measure | Guardant Health | Industry median |
|---|---|---|
| Earnings Yield | -2.14% | -1.25% |
| FCF Yield | -1.14% | 1.74% |
| Buyback Yield | 0.00% | 0.32% |
| Shareholder Yield | 0.00% | 0.65% |
Shares
| Measure | Guardant Health | Industry median |
|---|---|---|
| Shares Outstanding | 134,196,000 | 58,282,400 |
| Shares Change (YoY) | 4.62% | 2.68% |
| Shares Change (QoQ) | 1.60% | 0.32% |
| Float | 131,604,000 | 33,780,100 |
| Shares Held by Insiders | 1.93% | 16.4% |
| Shares Held by Institutions | 99.8% | 85.9% |
Taxes
| Measure | Guardant Health | Industry median |
|---|---|---|
| Income Tax | -$1.03M | $697.00K |
Scores
| Measure | Guardant Health | Industry median |
|---|---|---|
| Altman Z-Score | 4.04 | 1.96 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.79 | -2.71 |
Calculated by StockData from Guardant Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.